As Wnt3a has been shown to promote proliferation of mouse pro-B cells through a Lef1-dependent mechanism, it seems plausible that B cells in CLL exploit the same mechanism during CLL pathogenesis. The gene discussed is LEF1; the disease is B-cell chronic lymphocytic leukemia.